ZOGENIX INTERNATIONAL LIMITED
Get an alert when ZOGENIX INTERNATIONAL LIMITED files next
Leroy will email you the moment a new filing lands at Companies House — one short note per filing, nothing else.
Next accounts due
2026-09-30 (in 4mo)
Last filed for 2024-12-31
Confirmation statement due
2026-05-29 (this month)
Last made up 2025-05-15
Watchouts
Cash
—
Latest balance sheet
Net assets
-£280M
-4.6% vs 2023
Employees
—
Average over period
Profit before tax
£2M
+154.3% vs 2023
Watchouts
Facts from the Companies House register and the latest accounts — not a rating
-
1 PSC ceased in last 24 months
Significant control changed hands — see the Ownership section.
Name history
Renamed 1 time since incorporation
- ZOGENIX INTERNATIONAL LIMITED 2015-11-17 → present
- BRABANT PHARMA LIMITED 2012-12-13 → 2015-11-17
Net assets
2-year trend · vs Industrials median
Accounts
2-year trend · latest reflected 2024-12-31
| Metric | Trend | 2023-12-31 | 2024-12-31 |
|---|---|---|---|
| Turnover | £95,639,328 | £52,054,680 | |
| Operating profit | -£3,329,199 | £25,149,313 | |
| Profit before tax | -£3,250,360 | £1,764,655 | |
| Net profit | -£3,393,692 | -£12,205,130 | |
| Cash | — | — | |
| Total assets less current liabilities | £62,180,967 | -£24,414,820 | |
| Net assets | -£267,954,687 | -£280,159,816 | |
| Equity | -£267,954,687 | -£280,159,816 | |
| Average employees | — | — | |
| Wages | — | — |
Values shown as filed in the company's annual accounts. — indicates the figure wasn't present under that line item in that period. About these numbers
Ratios
Computed from the line items above — sparklines read oldest → newest
| Ratio | Trend | 2023-12-31 | 2024-12-31 |
|---|---|---|---|
| Operating margin | -3.5% | 48.3% | |
| Net margin | -3.5% | -23.4% | |
| Return on capital employed | -5.4% | -103.0% | |
| Gearing (liabilities / total assets) | 944.5% | 1239.2% | |
| Current ratio | 22.21x | 0.38x | |
| Interest cover | -42.23x | 0.99x |
Margins divide P&L lines by turnover. Gearing is liabilities over total assets. Current ratio is current assets over creditors falling due within one year. Interest cover is operating profit over absolute finance costs. Sector-distribution context coming next.
Audit & accounting basis
- Accounting basis
- FRS 102
- Reporting scope
- Standalone (parent only)
- Auditor
- Zome Audit Limited
- Audit opinion
- Unqualified (clean)
- Going concern
- Affirmed
“The directors consider that the Company has adequate resources to continue in business in the foreseeable future and that it is therefore appropriate to adopt the going concern basis in preparing the Financial Statements.”
Group structure
- ZOGENIX INTERNATIONAL LIMITED · parent
- Zogenix ROI Limited 100%
Auditor, going-concern and subsidiary information is drawn from the narrative of the latest annual accounts. About these numbers
People
3 active · 19 resigned
| Name | Role | Appointed | Born | Nationality |
|---|---|---|---|---|
| KHATRI, Yogesh | Director | 2022-04-29 | Oct 1965 | British |
| REYNDERS, Nico Victor | Director | 2024-12-01 | Aug 1972 | Belgian |
| SHAH, Viral Rohit | Director | 2022-04-29 | May 1985 | British |
Show 19 resigned officers
| Name | Role | Appointed | Resigned |
|---|---|---|---|
| BREW, Emma Rose | Secretary | 2022-01-01 | 2023-02-03 |
| RADIUS COMMERCIAL SERVICES LIMITED | Corporate Secretary | 2015-07-01 | 2018-04-24 |
| BARKER, Gavin Andrew, Dr | Director | 2015-12-01 | 2022-06-30 |
| CLARKE, Anthony, Dr | Director | 2013-01-15 | 2014-10-24 |
| DARCIS, Thierry Jean Philippe | Director | 2015-09-22 | 2017-11-22 |
| FARFEL, Gail, Dr | Director | 2015-12-01 | 2022-06-30 |
| FARR, Stephen James, Dr | Director | 2014-10-24 | 2021-06-28 |
| GALER, Bradley Stuart | Director | 2016-09-15 | 2022-04-29 |
| HAWLEY, Roger | Director | 2014-10-24 | 2015-08-11 |
| MCNAUGHT, Daniel James | Director | 2021-06-28 | 2022-08-19 |
| MISTRY, Arun Govindbhai | Director | 2015-12-01 | 2019-08-30 |
| PEYTON, Duncan Joseph | Director | 2012-12-13 | 2014-10-24 |
| RHOADS, Ann | Director | 2014-10-24 | 2017-03-13 |
| SAGROLIKAR, Ashish Manohar | Director | 2021-06-28 | 2022-04-29 |
| SMITH, Michael Patrick | Director | 2017-03-22 | 2022-03-18 |
| STEVENSON, Alexander James | Director | 2013-03-08 | 2014-10-24 |
| STEWART, Richard | Director | 2013-01-15 | 2014-10-24 |
| WAERNER, Lars Uno Torbjorn | Director | 2021-06-28 | 2022-06-30 |
| WILLIAMS, Alexander David Robert | Director | 2016-09-15 | 2018-05-03 |
Ownership
Persons with significant control
| Name | Kind | Nature of control | Notified | Status |
|---|---|---|---|---|
| Ucb Biosciences Inc. | Corporate entity | Shares 75–100%, Voting 75–100%, Appoints directors | 2026-01-12 | Active |
| Zogenix Europe Limited | Corporate entity | Shares 75–100%, Voting 75–100% | 2016-04-06 | Ceased 2026-01-12 |
Filing timeline
Last 20 of 103 total filings
| Date | Type | Category | Description | |
|---|---|---|---|---|
| 2026-01-13 | PSC07 | persons-with-significant-control | Cessation of a person with significant control | |
| 2026-01-13 | PSC02 | persons-with-significant-control | Notification of a person with significant control | |
| 2025-09-25 | AA | accounts | Accounts with accounts type full | |
| 2025-05-21 | CS01 | confirmation-statement | Confirmation statement with no updates | |
| 2025-02-01 | AD01 | address | Change registered office address company with date old address new address | |
| 2025-01-31 | AD01 | address | Change registered office address company with date old address new address | |
| 2025-01-31 | AD01 | address | Change registered office address company with date old address new address | |
| 2024-12-05 | AP01 | officers | Appoint person director company with name date | |
| 2024-10-03 | AA | accounts | Accounts with accounts type full | |
| 2024-05-21 | CS01 | confirmation-statement | Confirmation statement with no updates | |
| 2023-11-02 | AA | accounts | Accounts with accounts type full | |
| 2023-05-18 | CS01 | confirmation-statement | Confirmation statement with no updates | |
| 2023-04-03 | AA | accounts | Accounts with accounts type full | |
| 2023-02-06 | TM02 | officers | Termination secretary company with name termination date | |
| 2022-09-20 | TM01 | officers | Termination director company with name termination date | |
| 2022-07-11 | TM01 | officers | Termination director company with name termination date | |
| 2022-07-11 | TM01 | officers | Termination director company with name termination date | |
| 2022-07-11 | TM01 | officers | Termination director company with name termination date | |
| 2022-05-25 | CS01 | confirmation-statement | Confirmation statement with no updates | |
| 2022-05-17 | TM01 | officers | Termination director company with name termination date |
Public-record activity
Raw counts from Companies House — last 12–24 months
- Filings
- 4
- Capital events
- 0
- Officers appointed
- 0
- Officers resigned
- 0
last 12 months
last 24 months
last 12 months
last 12 months
Direct counts from the register. No score, no rating — see the Filing timeline for the underlying events.
Year-on-year
FY2023 → FY2024 · period ending 2024-12-31 vs 2023-12-31
-
Turnover
-45.6%
£95,639,328 £52,054,680
-
Cash
—
Not reported
-
Net assets
-4.6%
-£267,954,687 -£280,159,816
-
Employees
—
Not reported
-
Operating profit
+855.4%
-£3,329,199 £25,149,313
-
Profit before tax
+154.3%
-£3,250,360 £1,764,655
Each % is (latest − prior) ÷ |prior| for the line item as filed. The comparison is only shown when the latest and prior accounts cover broadly equal-length periods — short or long stubs (typical around incorporation or a year-end change) are suppressed rather than misrepresented. Lines a company doesn't report are omitted. About these numbers